Key Highlights: Implications: Cipla’s licensing deal adds a potential new HER2-targeted cancer treatment to its pipeline in India, South Africa and five other emerging markets, stren...
Summary The Top 10 R&D Spending Indian Biopharma Companies of 2026 reflect the country’s growing commitment to pharmaceutical innovation, advanced drug develop...
Summary: The Top 10 Indian Pharmaceutical Companies of 2026 demonstrate the continued strength and global competitiveness of India’s pharmaceutical sector, led by Sun Pharmaceutical Industries, ...
Summary The Top 10 Generic Pharmaceutical Companies of 2025 highlight the continued growth and resilience of the global generics industry, led by Sandoz, Sun Pharma, and Fosun Pharma....
